← Back to search

Mana Bio

AI-powered design of lipid nanoparticles (LNPs) for genetic medicines with better safety and tropism

a16zActive

What they do

Problem

Genetic medicines need lipid nanoparticles that can deliver payloads to the right tissues with improved safety, but current LNPs have limited tropism and tolerability.

Solution

An AI-powered platform that designs lipid nanoparticles (LNPs) optimized for safety and tissue-specific delivery of genetic medicine payloads.

Who it's for

Biopharma and biotech companies developing genetic medicines (e.g., mRNA, siRNA, gene editing) that require LNP delivery systems.

Company timeline

Similar startups

Inceptive
Foundation models for molecule design, customized for partners to ena…
Junction Bioscience
AI Hypothesis Engine for Molecular Discovery
Exonic
Unsupervised Biological AI
Verge Genomics
We use human data and AI to develop better drugs faster.
AminoAnalytica
The AI-Native Operating System for Protein Engineering
Ångström AI
Gen AI molecular simulations that reproduce wetlab results